What Is GLP-1? The Biology Behind the Hormone Powering Modern Weight Loss

You've probably heard about GLP-1 medications — Ozempic, Wegovy, Mounjaro — without ever hearing what GLP-1 actually is. The answer is more interesting than the marketing suggests. GLP-1 is a hormone your body produces every time you eat. It tells your brain you're full, tells your stomach to slow down, tells your pancreas to release insulin, and tells your liver to stop releasing sugar. Modern GLP-1 medications are synthetic versions that work for a week at a time instead of two minutes.

This guide is the biology. No marketing, no shortcuts. By the end you'll understand exactly what GLP-1 does in your body, why drug analogs are so much more potent than the natural hormone, and what that translates to in terms of weight loss.

What GLP-1 actually is

GLP-1 = glucagon-like peptide-1. It's a small protein (a peptide) made of about 30 amino acids.

It's an incretin hormone — meaning it's released from your gut in response to food intake and helps regulate the body's response to that food.

Specifically, GLP-1 is produced by specialized intestinal cells called L cells, which sit primarily in the ileum and colon (the lower portions of your small intestine and large intestine). When you eat a meal — particularly one containing carbohydrates or fats — these L cells release GLP-1 into your bloodstream within 10 – 15 minutes.

The native hormone is extremely short-lived: its half-life in the bloodstream is about 1 – 2 minutes, because an enzyme called DPP-4 (dipeptidyl peptidase-4) rapidly chews it up. This short half-life is the reason your body releases GLP-1 in pulses around meals — and it's the reason drug developers had to chemically modify the molecule to make medications that last for a week.

What GLP-1 does in your body

GLP-1 has effects in at least four major systems:

1. Pancreas — glucose-dependent insulin release

When blood sugar rises (after a meal), GLP-1 stimulates insulin release from pancreatic beta cells. Critically, this effect is glucose-dependent — GLP-1 only increases insulin release when blood sugar is actually elevated. This is why GLP-1 medications don't cause severe hypoglycaemia the way older diabetes drugs (like sulfonylureas) do.

GLP-1 also suppresses glucagon release from pancreatic alpha cells. Glucagon is the hormone that tells your liver to release stored sugar. Suppressing glucagon further lowers blood sugar.

2. Stomach — slower gastric emptying

GLP-1 slows the rate at which food leaves your stomach. This is one of the most clinically important effects:

• Food stays in your stomach longer
• You feel fuller for longer
• Blood sugar rises more gradually
• Hunger returns later

The slowed gastric emptying is also the mechanism behind most GLP-1 side effects — nausea, mild reflux, occasional vomiting at higher doses. The same effect that makes you feel full causes mild GI discomfort initially.

3. Brain — satiety and reward signalling

GLP-1 receptors are present in the hypothalamus (the brain region controlling hunger), the brainstem (which processes satiety signals), and the mesolimbic reward system (which drives motivation to eat).

GLP-1's brain effects:

• Increases satiety signals ("I am full")
• Reduces hunger signals ("I need food")
• Reduces food reward — meaning food feels less rewarding, cravings quieten, the constant mental loop of food thoughts ("food noise") gets quieter
• Slightly reduces gastric motility via vagal pathways

This is the effect patients on Wegovy and Mounjaro most often comment on — not the gut effects, but the mental quietening around food.

4. Liver — reduced glucose production

GLP-1 reduces the liver's production of glucose (gluconeogenesis), particularly via the glucagon-suppression effect above. This contributes to overall blood-sugar control.

How GLP-1 medications work

Native GLP-1 is too short-lived for therapeutic use — you'd have to infuse it continuously to get a meaningful effect. So drug developers chemically modified the molecule in two key ways:

1. Made it resistant to DPP-4 (the enzyme that destroys natural GLP-1)
2. Added components that bind to blood proteins (especially albumin), so the drug circulates for a week instead of minutes

This gives you a synthetic GLP-1 analog that:

• Has the same effects on the pancreas, stomach, brain, and liver as natural GLP-1
• But lasts ~165 hours (~1 week) in circulation instead of ~2 minutes
• Produces continuous, low-level GLP-1 receptor activation rather than the brief post-meal spikes of the natural hormone

The result: sustained appetite suppression, slower gastric emptying, improved blood sugar control, and meaningful weight loss over weeks and months.

What's different about each GLP-1 drug

Drug	Modification strategy	Half-life	Dosing frequency
Liraglutide (Victoza, Saxenda)	Fatty acid attached to bind albumin	~13 hours	Daily
Exenatide ER (Bydureon)	Exendin-4 (Gila monster molecule) in slow-release microspheres	~weeks	Weekly
Semaglutide (Ozempic, Wegovy, Rybelsus)	Modified amino acids + fatty acid chain	~165 hours (~1 week)	Weekly (injection) or daily (oral)
Tirzepatide (Mounjaro)	Dual GLP-1 + GIP activity; modified for albumin binding	~120 hours	Weekly
Dulaglutide (Trulicity)	GLP-1 fused to immunoglobulin Fc region	~5 days	Weekly

Tirzepatide is the outlier — it's not just a GLP-1 agonist. It activates both GLP-1 receptors and GIP receptors (GIP = glucose-dependent insulinotropic polypeptide, another incretin hormone). This dual activation is the leading hypothesis for why tirzepatide produces larger weight loss than semaglutide in clinical trials.

Why GLP-1 medications cause weight loss (the full picture)

Several mechanisms stack:

1. Reduced appetite → you simply want to eat less
2. Slower gastric emptying → you feel full faster and stay full longer
3. Reduced food reward → cravings quieten; eating becomes more functional
4. Better blood sugar control → fewer insulin spikes and crashes (which drive hunger in their own right)
5. Possible direct effects on metabolic rate — debated, mechanisms still being studied

The combined effect is typically a 400 – 700 kcal/day spontaneous reduction in intake at therapeutic doses, which produces the 1 – 2 kg/month weight loss seen in trials. This isn't medication "burning fat" — it's medication making the calorie deficit dramatically more achievable.

What GLP-1 doesn't do

Worth being clear about:

• Doesn't directly burn fat — calorie deficit does the work; GLP-1 makes the deficit possible
• Doesn't build muscle — resistance training + protein intake does that
• Doesn't change basal metabolic rate dramatically — modest effects, mostly indirect via lean mass changes
• Doesn't work without behavioural change — patients who lose the most weight pair GLP-1 with structured nutrition + movement
• Doesn't permanently change appetite regulation — most patients return toward pre-treatment appetite within weeks of stopping the medication

The other things GLP-1 may do (active research areas)

The GLP-1 receptor is present in many tissues beyond the four major systems. Active research is exploring effects on:

• Cardiovascular system — established benefit in patients with established CVD (SELECT trial, 2023)
• Kidney — emerging evidence of renal protection (FLOW trial, 2024)
• Liver — improvement in NAFLD / MASLD with weight loss
• Brain — addiction, alcohol use disorder (early data); possible Alzheimer's protection (early data)
• Inflammation — reduction in systemic inflammatory markers

Some of these are now established clinical indications; others are early-stage research. The picture in 2030 will likely include GLP-1 use for several conditions beyond diabetes and weight management.

GLP-1 and weight regain after stopping

A critical biological fact: GLP-1 medications don't permanently change your weight set point.

The body's regulation of hunger and satiety remains driven by your natural physiology — your baseline GLP-1 production, your leptin, your ghrelin, your insulin resistance. GLP-1 medication overrides these signals as long as you're taking it. When you stop, your body's natural settings return.

This is why the STEP-4 trial (Rubino et al., JAMA 2021) showed patients regaining ~two-thirds of lost weight within a year of switching from semaglutide to placebo, while continuers maintained loss.

The implication: GLP-1 is best thought of as chronic-condition medication (like medication for hypertension or cholesterol) rather than a short-term intervention. Continuation, transition, and long-term planning is part of treatment.

Frequently asked questions

Is GLP-1 a hormone or a drug? Both. GLP-1 is a naturally occurring gut hormone. GLP-1 medications are synthetic analogs of that hormone, chemically modified to last a week instead of minutes.

Does my body produce GLP-1 naturally? Yes, every time you eat. Your gut releases GLP-1 within 10 – 15 minutes of food intake. The natural pulses are short and small; drug analogs produce sustained, larger effects.

Why does GLP-1 medication make me feel full? Combination of slower gastric emptying (food stays in your stomach longer), increased satiety signals in your brain, and reduced reward signals around food.

Is GLP-1 the same as Ozempic? GLP-1 is the natural hormone. Ozempic is a brand of semaglutide, which is a synthetic GLP-1 analog. The same molecule is sold as Wegovy (for weight) and Rybelsus (oral).

Why is tirzepatide (Mounjaro) more effective than semaglutide? Tirzepatide activates both GLP-1 receptors and GIP receptors. The dual activation appears to produce larger appetite suppression and weight loss than GLP-1 activation alone, though the exact mechanism is still being characterized.

Do GLP-1 medications work the same in everyone? No — individual response varies widely. Genetics, gender, age, baseline metabolic state, adherence, diet, sleep, and other factors all influence outcomes. A subgroup responds dramatically; a smaller subgroup loses very little.

Will my body adapt to the medication so it stops working? True tachyphylaxis (drug stopping working) is uncommon. Plateaus during weight loss are usually about reaching a new metabolic equilibrium, not the medication losing effect.

Can I increase my natural GLP-1 production without medication? Modestly, through dietary fibre, protein-rich meals, and certain fermented foods. The effect is much smaller than medication. Useful as an adjunct, not as a substitute.

Ready to learn what GLP-1 could do for you?

Check your eligibility — your Stride assessment + consultation includes a clinician explaining how GLP-1 (if appropriate for you) works in your specific case.